Knowledge Distillery

Genomic evidence for reinfection with SARS-CoV-2: a case study

Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species

BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants

Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals

Risk of hospital admission for patients with SARS-CoV-2 variant B.1.1.7: cohort analysis

Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum

Increased transmissibility and global spread of SARSCoV-2 variants of concern as at June 2021

The emergence of SARS-CoV-2 variants threatens progress toward control of the Covid-19 pandemic. In a phase 1–2 trial involving healthy adults, the…

Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant

A new variant of SARS-CoV-2, B.1.1.7, emerged as the dominant cause of COVID-19 disease in the UK from November, 2020. In this article the authors…

Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study

The objective of this matched cohort study was to establish whether there is any change in mortality from infection with a new variant of SARS-CoV-2 ,…